天辰生物
 

Home > Platform > SunDoma™



SunDomaTM is a technology platform of the super high affinity antilbody developed by Longbio. The platform is developed based on the 30+ years' experience in hybridoma technology by the co-founder, Dr. Sun Nai-chau. Based on this platform, Longbio has developed a series of high affinity antibodies, including LP-003, the new generation of anti-IgE antibody.

Unique immune preparation
Unique immune approach
Hybridoma cells fusion
Single B cells
Multiple screening methods
Efficient to screen out target mab
Finish

High affinity antibody that developed by SundomaTM platform (KD)

(All KD data above are detected by KinExA)